Bazazzadegan Niloofar, Abedini Seyedeh Sedigheh, Azarkeivan Azita, Banihashemi Susan, Nikzat Nooshin, Najmabadi Hossein, Neishabury Maryam
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Hemoglobin. 2023 Nov;47(4):147-151. doi: 10.1080/03630269.2023.2242787. Epub 2023 Aug 7.
Beta Thalassemia is the most prevalent and well-studied single gene disorder in Iran. Here, we investigated the spectrum of gene mutations, identified among 2315 patients, referred to a reference thalassemia clinic in Tehran, on the basis of suspicion to thalassemia major or intermedia. The patients were homozygous or compound heterozygous for mutations, and were referred from various Iranian provinces, during 15 years (2001- 2016). The mutations were classified based on their frequency, and the result was compared to a meta-analysis of 14,293 beta thalassemia cases in the Iranian population, within the same time period. The mutation spectrum in this study contained 43 mutations, compared to the 90, presented by the meta-analysis. Similar to the meta-analysis, IVSII-1 (G > A) and IVSI-5 (G > C) were the most common mutations in this study. These two comprised 62.40% of the total mutant alleles in the studied population, comparable to 51.92% of that in the meta-analysis. IVSII-1 (G > A) and IVSI-5 (G > C), followed by 17 other mutations that had frequencies ranging from 0.15% to 5.44%, were among the 20 common mutations in Iran and neighboring countries, according to the meta-analysis. This study provided further evidence to support the spectrum of the most common mutations in the Iranian population.
β地中海贫血是伊朗最普遍且研究充分的单基因疾病。在此,我们调查了2315例因疑似重型或中间型地中海贫血而转诊至德黑兰一家地中海贫血参考诊所的患者中所发现的基因突变谱。这些患者为突变的纯合子或复合杂合子,在15年期间(2001 - 2016年)从伊朗不同省份转诊而来。根据突变频率对这些突变进行分类,并将结果与同一时期伊朗人群中14293例β地中海贫血病例的荟萃分析结果进行比较。本研究中的突变谱包含43种突变,而荟萃分析显示有90种。与荟萃分析相似,IVSII - 1(G>A)和IVSI - 5(G>C)是本研究中最常见的突变。这两种突变在所研究人群的总突变等位基因中占62.40%,与荟萃分析中的51.92%相当。根据荟萃分析,IVSII - 1(G>A)和IVSI - 5(G>C),以及其他17种频率在0.15%至5.44%之间的突变,是伊朗及周边国家20种常见的β突变之一。本研究为支持伊朗人群中最常见的β突变谱提供了进一步的证据。